Patel S C, Tovee E B, Langer B
Surgery. 1977 Oct;82(4):460-5.
Between the years 1950 and 1975, 1,100 patients with carcinoma of the rectum were seen at the Toronto General Hospital. Of these, 519 had tumors below the peritoneal reflection. The resection rate in this latter group of patients was 94%. One hundred and thirty-three patients were treated by low anterior resection (LAR) and 316 by combined abdominoperineal resection (APR). Although the incidence of postoperative complications was high (LAR 41%, APR 53%), the operative mortality was low (LAR 2.2%, APR 2.9%). Recurrent tumor appeared more frequently in the pelvis (24%) than at distant sites (18%), was more common in more advanced disease, and correlated with the incidence of late death. The overall (actuarial) survival figures were 50% at 5 years and 37% at 10 years, with no significant difference between LAR and APR. For curative resections, the 5- and 10-year survival figures were 59% and 44%, respectively. Clinical staging (Dukes) influenced survival greatly, both at 5 years (Dukes A 77%, B 65%, C 33%, D 3%) and at 10 years (Dukes A 55%, B 53%, C 20%, D 0%). The level of the lesion did not influence either recurrence rate or survival.
1950年至1975年间,多伦多综合医院共接诊了1100例直肠癌患者。其中,519例患者的肿瘤位于腹膜反折以下。后一组患者的切除率为94%。133例患者接受了低位前切除术(LAR),316例接受了腹会阴联合切除术(APR)。虽然术后并发症的发生率较高(LAR为41%,APR为53%),但手术死亡率较低(LAR为2.2%,APR为2.9%)。复发性肿瘤在盆腔出现的频率更高(24%),而非远处部位(18%),在病情更晚期的患者中更常见,且与晚期死亡率相关。总体(精算)生存率在5年时为50%,10年时为37%,LAR和APR之间无显著差异。对于根治性切除术,5年和10年生存率分别为59%和44%。临床分期(Dukes分期)对生存率影响极大,5年时(Dukes A期为77%,B期为65%,C期为33%,D期为3%)和10年时(Dukes A期为55%,B期为53%,C期为20%,D期为0%)均如此。病变位置对复发率和生存率均无影响。